We are live on
!
Find out more
DA
Dillon & Associates Portfolio holdings
AUM
$726M
1-Year Est. Return
18.59%
This Fund
S&P 500
This Quarter
Est. Return
+5.13%
1 Year Est. Return
+18.59%
3 Year Est. Return
+92.03%
5 Year Est. Return
+130.73%
10 Year Est. Return
+511.58%
AUM
$253M
AUM Growth
+$10.8M
(+4.5%)
Cap. Flow
-$233K
Cap. Flow
% of AUM
-0.09%
Top 10 Holdings %
Top 10 Hldgs %
45.22%
Holding
72
New
1
Increased
29
Reduced
30
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Euronet Worldwide
EEFT
|
+$1.08M |
| 2 |
Walt Disney
DIS
|
+$593K |
| 3 |
Cognizant
CTSH
|
+$314K |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$274K |
| 5 |
JPMorgan Chase
JPM
|
+$221K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLB Ltd
SLB
|
+$699K |
| 2 |
Qualcomm
QCOM
|
+$488K |
| 3 |
Enbridge
ENB
|
+$467K |
| 4 |
Genuine Parts
GPC
|
+$386K |
| 5 |
Analog Devices
ADI
|
+$206K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.74% |
| 2 | Technology | 18.55% |
| 3 | Consumer Staples | 13.02% |
| 4 | Industrials | 10.07% |
| 5 | Communication Services | 9.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Coca-Cola
KO
$377B
| $534K | 0.21% |
11,871
-1,400
| -11% | -$63.7K |
|
52
ExxonMobil
XOM
$644B
| $534K | 0.21% |
6,507
+129
| +2% | +$10.2K |
|
53
Biogen
BIIB
$30B
| $460K | 0.18% |
1,470
+10
| +0.7% | +$2.96K |
|
54
Core Laboratories
CLB
$488M
| $441K | 0.17% |
4,450
-500
| -10% | -$48.5K |
|
55
Cisco
CSCO
$457B
| $435K | 0.17% |
12,792
-975
| -7% | -$31K |
|
56
AT&T
T
$159B
| $383K | 0.15% |
12,999
+376
| +3% | +$10.7K |
|
57
CVS Health
CVS
$133B
| $368K | 0.15% |
4,545
-830
| -15% | -$65.7K |
|
58
Honeywell
HON
$77B
| $334K | 0.13% |
2,601
+155
| +6% | +$19.2K |
|
|
ESRX
59
DELISTED
Express Scripts Holding Company
ESRX
| $318K | 0.13% |
5,050
+15
| +0.3% | +$932 |
|
60
Eaton
ETN
$161B
| $308K | 0.12% |
4,006
| – | – |
|
61
Bristol-Myers Squibb
BMY
$133B
| $270K | 0.11% |
4,225
| – | – |
|
62
Constellation Brands
STZ
$22.2B
| $265K | 0.1% |
1,331
+36
| +3% | +$7.13K |
|
63
Kraft Heinz
KHC
$30.7B
| $264K | 0.1% |
3,387
| – | – |
|
64
Emerson Electric
EMR
$83.9B
| $256K | 0.1% |
4,057
| – | – |
|
|
CMA
65
DELISTED
Comerica
CMA
| $249K | 0.1% |
3,271
-86
| -3% | -$6.16K |
|
66
IBM
IBM
$211B
| $232K | 0.09% |
1,674
| – | – |
|
67
DuPont de Nemours
DD
$18.5B
| $214K | 0.08% |
+1,227
| New | +$205K |
|
68
Wells Fargo
WFC
$261B
| $208K | 0.08% |
3,775
| – | – |
|
69
Merck
MRK
$322B
| $200K | 0.08% |
3,280
| – | – |
|
|
GCVRZ
70
DELISTED
Sanofi Contingent Value Rights
GCVRZ
| $4K | ﹤0.01% |
10,660
| – | – |
|
|
71
Analog Devices
ADI
$179B
| – | – |
-2,638
| Closed | -$206K |
|
|
72
Genuine Parts
GPC
$17.1B
| – | – |
-4,155
| Closed | -$386K |
|
Similar funds
TC
F
SDH
SCM
MWP
FAN
TFHU
AGAM
Dillon & Associates's Q3 2017 Portfolio in Review
As of Q3 2017, Dillon & Associates held 72 positions worth $253M, up 4.5% from $243M the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Trading was light in Q3 2017: portfolio turnover was 4.2%. Dillon & Associates opened 1 new position and exited 2, leaving the 72-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 25% a quarter earlier, followed by Technology and Consumer Staples.
- Dillon & Associates's largest Q3 2017 buy was DuPont de Nemours: 1,227 shares worth $214K.
- Dillon & Associates added most to Euronet Worldwide in Q3 2017, an estimated $1.08M increase.
- Dillon & Associates's biggest Q3 2017 reduction was SLB Ltd, cutting an estimated $699K.
- Dillon & Associates fully exited Genuine Parts in Q3 2017, selling an estimated $386K.
- Dillon & Associates's ten largest holdings make up 45% of its $253M portfolio in Q3 2017.
- Dillon & Associates opened 1 new position and closed 2 in Q3 2017.
- Dillon & Associates's portfolio value rose 4.5% quarter-over-quarter to $253M.
Based on Dillon & Associates's 13F filing for Q3 2017, filed 13 Nov 2017.